MUX Insider: Brissenden Exercises Options and Executes Open-Market Sales
Rhea-AI Filing Summary
Insider transactions by Richard W. Brissenden at McEwen Inc. (MUX) show multiple option exercises and open-market sales on 09/22/2025. Mr. Brissenden exercised a $1.25 option for 7,500 shares that was nearing its 09/28/2025 expiration and a $7.10 option for 8,334 shares (vesting schedule noted). He sold 6,428 shares at a weighted average price of $14.8885 and 4,775 shares at a weighted average price of $14.8834. After these trades he beneficially owned 12,964 shares and held 8,333 exercisable shares from the $7.10 option.
Positive
- Exercise of near-expiring option: 7,500-share option at $1.25 was exercised before its 09/28/2025 expiration
- Disclosure clarity: Form includes weighted-average price explanations and vesting schedule details
Negative
- Insider sales: 11,203 shares sold on 09/22/2025 at weighted average prices of $14.8885 and $14.8834, reducing holdings
- Reduced direct holdings: Beneficial ownership after transactions is 12,964 shares, lower than pre-transaction totals reported
Insights
TL;DR: Insider exercised near-expiring option and sold portions of holdings; net position changed but appears routine.
The reporting shows timely exercise of a $1.25 option for 7,500 shares immediately before expiration and exercise/vesting activity for a $7.10 option covering 8,334 shares. Offset by open-market sales totaling 11,203 shares at weighted average prices near $14.89, the reporting person still holds 12,964 shares plus 8,333 exercisable option shares. This pattern — exercise followed by partial sale — is consistent with liquidity management around option expirations rather than a corporate event. Impact on outstanding float is likely immaterial based on disclosed quantities alone.
TL;DR: Form 4 discloses timely compliance and clearly explains weighted-average sale prices; no governance red flags disclosed.
The Form 4 is complete and includes required explanations for weighted-average sale prices across multiple transactions. It discloses the reporting persons status as a director and shows exercises and sales on a single date, with vesting schedules for option grants noted. There are no indications of rule non-compliance, related-party transactions, or unusual delegation of authority. From a governance perspective, the filing meets disclosure expectations for Section 16 insiders.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (right to buy) | 7,500 | $0.00 | -- |
| Exercise | Stock Option (right to buy) | 8,334 | $0.00 | -- |
| Exercise | Common Stock | 7,500 | $1.25 | $9K |
| Sale | Common Stock | 6,428 | $14.8885 | $96K |
| Exercise | Common Stock | 8,334 | $7.10 | $59K |
| Sale | Common Stock | 4,775 | $14.8834 | $71K |
Footnotes (1)
- The price reported in Column 4 is a weighted average price. The Reporting Person sold shares in multiple transactions at prices ranging from $14.85 to $15.025. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. The price reported in Column 4 is a weighted average price. The Reporting Person sold shares in multiple transactions at prices ranging from $14.85 to $14.915. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. The option vested in three equal annual installments, beginning September 29, 2021. The option vests in three equal annual installments, beginning June 29, 2024.
